Betahistini dihydrochloride
The active substance in Betahistyne Bluefish is betahistini dihydrochloride. This medicine is called a "histamine analogue". The medicine is used to treat:
Symptoms of Meniere's disease, such as vertigo of labyrinthine origin, tinnitus, hearing loss with accompanying nausea, balance disorders and (or) headache:
This medicine should not be used if the patient has any of these conditions. Before starting to take Betahistyne Bluefish, the patient should talk to their doctor or pharmacist.
Before starting to take Betahistyne Bluefish, the patient should discuss it with their doctor.
Before starting to take Betahistyne Bluefish, the patient should talk to their doctor or pharmacist.
This medicine should not be used if the patient has any of these conditions (or is unsure). Before starting to take Betahistyne Bluefish, the patient should talk to their doctor or pharmacist. It may be necessary to closely monitor the patient's condition while taking Betahistyne Bluefish.
Children
Betahistyne Bluefish is not recommended for use in children.
The patient should tell their doctor or pharmacist about all medicines they are taking, or have recently taken, as well as any medicines they plan to take.
In particular, the patient should inform their doctor or pharmacist if they are taking any of the following medicines:
Betahistyne Bluefish can be taken with or without food. However, Betahistyne Bluefish may cause mild stomach disorders (see section 4). Taking Betahistyne Bluefish with food may help reduce stomach disorders.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
It is not known whether Betahistyne Bluefish affects the unborn child:
It is not known whether betahistyne passes into breast milk.
It is unlikely that Betahistyne Bluefish will affect the ability to drive or use machines. However, the patient should remember that the diseases being treated with Betahistyne Bluefish (vertigo, tinnitus, and hearing loss associated with Meniere's disease) can cause dizziness and nausea, which may affect the ability to drive or use machines.
This medicine should always be taken as directed by the doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist. The doctor will adjust the dose individually for each patient.
The recommended dose is:
Tablets, 8 mg:one or two tablets, 3 times a day.
Tablets, 16 mg:half a tablet or one tablet, 3 times a day.
The patient should always follow the doctor's advice, as the doctor may adjust the dose.
If the patient takes more than one tablet a day, they should space out the tablets evenly throughout the day.
The patient should try to take the tablet at the same time every day. This will help ensure that a steady amount of the medicine is in the body. Taking the tablets at the same time will also help the patient remember to take them.
If the patient takes too many Betahistyne Bluefish tablets, they may experience nausea, drowsiness, or stomach pain. In case of doubt, the patient should consult their doctor.
If the patient forgets to take a tablet, they should skip that dose. They should wait until it is time to take the next dose. The patient should not take a double dose to make up for the missed tablet.
The patient should not stop taking Betahistyne Bluefish without consulting their doctor, even if they feel better.
In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Betahistyne Bluefish can cause side effects, although not everybody gets them.
If an allergic reaction occurs (frequency not known), the patient should stop taking Betahistyne Bluefish and contact their doctor or go to the nearest hospital immediately. Symptoms may include:
Frequent(may occur in up to 1 in 10 people):
Unknown(frequency cannot be estimated from the available data):
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: + 48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special precautions for storing the medicine.
The medicine should not be used after the expiry date stated on the carton after "Expiry date (EXP)". The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
8 mg: white, round, flat, uncoated tablets, 6.9 mm - 7.1 mm in size, smooth on both sides.
16 mg: white, round, biconvex, uncoated tablets, 8.6 mm - 8.8 mm in size, with a scored line on one side and "I" marking on both sides of the score line and smooth on the other side.
24 mg: white, round, biconvex, uncoated tablets, 9.9 mm - 10.1 mm in size, with a scored line on one side and "II" marking on both sides of the score line and smooth on the other side.
PVC/PVDC/Aluminum blisters: 20, 30, 50, 60, 90, and 100 tablets.
Bluefish Pharmaceuticals AB
P.O. Box 49013
100 28 Stockholm
Sweden
Bluefish Pharmaceuticals AB
Gävlegatan 22
113 30 Stockholm
Sweden
Date of last revision of the leaflet:December 2021
Member State | Medicinal product name |
Portugal (RMS) | Beta-histina Bluefish |
Poland | Betahistyne Bluefish |
Spain | Betahistina Bluefish 8mg/ 16mg comprimidos EFG |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.